Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)

被引:27
作者
Talaei, Mohammad [1 ]
Faustini, Sian [2 ]
Holt, Hayley [1 ,3 ,4 ]
Jolliffe, David A. [1 ,3 ]
Vivaldi, Giulia [1 ,3 ]
Greenig, Matthew [1 ]
Perdek, Natalia [1 ]
Maltby, Sheena [1 ]
Bigogno, Carola M. [1 ]
Symons, Jane [5 ]
Davies, Gwyneth A. [6 ]
Lyons, Ronan A. [6 ]
Griffiths, Christopher J. [1 ,4 ]
Kee, Frank [7 ]
Sheikh, Aziz [8 ]
Richter, Alex G. [2 ]
Shaheen, Seif O. [1 ]
Martineau, Adrian R. [1 ,3 ,4 ]
机构
[1] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Populat Hlth, London, England
[2] Univ Birmingham, Coll Med & Dent Sci, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England
[3] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England
[4] Queen Mary Univ London, Asthma UK Ctr Appl Res, London, England
[5] Jane Symons Media, London, England
[6] Swansea Univ, Med Sch, Populat Data Sci, Singleton Pk, Swansea, W Glam, Wales
[7] Queens Univ Belfast, Ctr Publ Hlth Res NI, Belfast, Antrim, North Ireland
[8] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland
基金
英国科研创新办公室;
关键词
SARS-CoV-2; Serology; Ethnicity; Diet; Micronutrients; Lifestyle; Exercise; Obesity; Alcohol; Occupation; INFECTION;
D O I
10.1186/s12916-022-02286-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Prospective population-based studies investigating multiple determinants of pre-vaccination antibody responses to SARS-CoV-2 are lacking. Methods We did a prospective population-based study in SARS-CoV-2 vaccine-naive UK adults recruited between May 1 and November 2, 2020, without a positive swab test result for SARS-CoV-2 prior to enrolment. Information on 88 potential sociodemographic, behavioural, nutritional, clinical and pharmacological risk factors was obtained through online questionnaires, and combined IgG/IgA/IgM responses to SARS-CoV-2 spike glycoprotein were determined in dried blood spots obtained between November 6, 2020, and April 18, 2021. We used logistic and linear regression to estimate adjusted odds ratios (aORs) and adjusted geometric mean ratios (aGMRs) for potential determinants of SARS-CoV-2 seropositivity (all participants) and antibody titres (seropositive participants only), respectively. Results Of 11,130 participants, 1696 (15.2%) were seropositive. Factors independently associated with higher risk of SARS-CoV-2 seropositivity included frontline health/care occupation (aOR 1.86, 95% CI 1.48-2.33), international travel (1.20, 1.07-1.35), number of visits to shops and other indoor public places (>= 5 vs. 0/week: 1.29, 1.06-1.57, P-trend = 0.01), body mass index (BMI) >= 25 vs. < 25 kg/m(2) (1.24, 1.11-1.39), South Asian vs. White ethnicity (1.65, 1.10-2.49) and alcohol consumption >= 15 vs. 0 units/week (1.23, 1.04-1.46). Light physical exercise associated with lower risk (0.80, 0.70-0.93, for >= 10 vs. 0-4 h/week). Among seropositive participants, higher titres of anti-Spike antibodies associated with factors including BMI >= 30 vs. < 25 kg/m(2) (aGMR 1.10, 1.02-1.19), South Asian vs. White ethnicity (1.22, 1.04-1.44), frontline health/care occupation (1.24, 95% CI 1.11-1.39), international travel (1.11, 1.05-1.16) and number of visits to shops and other indoor public places (>= 5 vs. 0/week: 1.12, 1.02-1.23, P-trend = 0.01); these associations were not substantially attenuated by adjustment for COVID-19 disease severity. Conclusions Higher alcohol consumption and lower light physical exercise represent new modifiable risk factors for SARS-CoV-2 infection. Recognised associations between South Asian ethnic origin and obesity and higher risk of SARS-CoV-2 seropositivity were independent of other sociodemographic, behavioural, nutritional, clinical, and pharmacological factors investigated. Among seropositive participants, higher titres of anti-Spike antibodies in people of South Asian ancestry and in obese people were not explained by greater COVID-19 disease severity in these groups.
引用
收藏
页数:18
相关论文
共 39 条
  • [1] [Anonymous], 2021, COVID 19 INFECT SURV
  • [2] [Anonymous], 2021, WHAT IS EC COST COVI
  • [3] Characteristics and Behaviors Associated with Prevalent SARS-CoV-2 Infection
    Aung, Sidney
    Vittinghoff, Eric
    Nah, Gregory
    Peyser, Noah D.
    Pletcher, Mark J.
    Olgin, Jeffrey E.
    Marcus, Gregory M.
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 1063 - 1067
  • [4] Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study
    Carrat, Fabrice
    de Lamballerie, Xavier
    Rahib, Delphine
    Blanche, Helene
    Lapidus, Nathanael
    Artaud, Fanny
    Kab, Sofiane
    Renuy, Adeline
    de Edelenyi, Fabien Szabo
    Meyer, Laurence
    Lydie, Nathalie
    Charles, Marie-Aline
    Ancel, Pierre-Yves
    Jusot, Florence
    Rouquette, Alexandra
    Priet, Stephane
    Villarroel, Paola Mariela Saba
    Fourie, Toscane
    Lusivika-Nzinga, Clovis
    Nicol, Jerome
    Legot, Stephane
    Druesne-Pecollo, Nathalie
    Esseddik, Younes
    Lai, Cindy
    Gagliolo, Jean-Marie
    Deleuze, Jean-Francois
    Bajos, Nathalie
    Severi, Gianluca
    Touvier, Mathilde
    Zins, Marie
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50 (05) : 1458 - 1472
  • [5] Risk factors for positive and negative COVID-19 tests: a cautious and in-depth analysis of UK biobank data
    Chadeau-Hyam, Marc
    Bodinier, Barbara
    Elliott, Joshua
    Whitaker, Matthew D.
    Tzoulaki, Ioanna
    Vermeulen, Roel
    Kelly-Irving, Michelle
    Delpierre, Cyrille
    Elliott, Paul
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2020, 49 (05) : 1454 - 1467
  • [6] Disparities of SARS-CoV-2 Nucleoprotein-Specific IgG in Healthcare Workers in East London, UK
    Choudhry, Naheed
    Drysdale, Kate
    Usai, Carla
    Leighton, Dean
    Sonagara, Vinay
    Buchanan, Ruaridh
    Nijjar, Manreet
    Thomas, Sherine
    Hopkins, Mark
    Cutino-Moguel, Teresa
    Gill, Upkar S.
    Foster, Graham R.
    Kennedy, Patrick T.
    [J]. FRONTIERS IN MEDICINE, 2021, 8
  • [7] Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients
    Cook, A. M.
    Faustini, S. E.
    Williams, L. J.
    Cunningham, A. F.
    Drayson, M. T.
    Shields, A. M.
    Kay, D.
    Taylor, L.
    Plant, T.
    Huissoon, A.
    Wallis, G.
    Beck, S.
    Jossi, S. E.
    Perez-Toledo, M.
    Newby, M. L.
    Allen, J. D.
    Crispin, M.
    Harding, S.
    Richter, A. G.
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2021, 494
  • [8] Coyle PV, 2021, ISCIENCE, V24, DOI [DOI 10.1016/j.isci.2021.102646, 10.1016/j.isci.2021.102646]
  • [9] Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study
    de Lusignan, Simon
    Dorward, Jienchi
    Correa, Ana
    Jones, Nicholas
    Akinyemi, Oluwafunmi
    Amirthalingam, Gayatri
    Andrews, Nick
    Byford, Rachel
    Dabrera, Gavin
    Elliot, Alex
    Ellis, Joanna
    Ferreira, Filipa
    Bernal, Jamie Lopez
    Okusi, Cecilia
    Ramsay, Mary
    Sherlock, Julian
    Smith, Gillian
    Williams, John
    Howsam, Gary
    Zambon, Maria
    Joy, Mark
    Hobbs, F. D. Richard
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (09) : 1034 - 1042
  • [10] Insights into SARS-CoV-2 Persistence and Its Relevance
    Desimmie, Belete A.
    Raru, Yonas Y.
    Awadh, Hesham M.
    He, Peimei
    Teka, Samson
    Willenburg, Kara S.
    [J]. VIRUSES-BASEL, 2021, 13 (06):